# IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
> **ANDA213565** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-03-10
## Drug
- **FDA Application Number:** ANDA213565
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
- **Generic name:** IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
- **Active ingredients:** IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurohealth LLC
- **First approval:** 2023-03-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213565)
---
*AI Analytics · CC0 1.0*